Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
about
Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.Effective downsizing but enhanced intratumoral heterogeneity following neoadjuvant sorafenib in patients with non-metastatic renal cell carcinoma.Genomic features of renal cell carcinoma with venous tumor thrombus.Prospective single center trial of next-generation sequencing analysis in metastatic renal cell cancer: the MORE-TRIAL.
P2860
Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Spatial niche formation but no ...... or intratumoural heterogeneity
@en
Spatial niche formation but no ...... r intratumoural heterogeneity.
@nl
type
label
Spatial niche formation but no ...... or intratumoural heterogeneity
@en
Spatial niche formation but no ...... r intratumoural heterogeneity.
@nl
prefLabel
Spatial niche formation but no ...... or intratumoural heterogeneity
@en
Spatial niche formation but no ...... r intratumoural heterogeneity.
@nl
P2093
P2860
P50
P356
P1476
Spatial niche formation but no ...... or intratumoural heterogeneity
@en
P2093
Bernd Lahrmann
Britta Walter
Carsten Grüllich
Cathleen Spath
Dirk Jäger
Dogu Teber
Gencay Hatiboglu
Gita Schönberg
Gregor Warsow
Joanne Nyarangi-Dix
P2860
P2888
P304
ncomms11845
P356
10.1038/NCOMMS11845
P407
P50
P577
2016-06-13T00:00:00Z